SCHEMBL2156331

SCHEMBL2156331

COC(=O)c1cc2[nH]cc(C3=CCCCC3)c2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
RAB9A P51151 2/20 0.35
MAPK1 P28482 2/20 0.35
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 3/20 0.34
MAPT P10636 2/20 0.34
GLA P06280 2/20 0.34
ATM Q13315 2/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CSNK2A2 P19784 1/20 0.32
KDR P35968 1/20 0.32
CSNK2B P67870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2867703 0.88 ACMSD (0.40) KDM4EALDH1A1HPGDCCNE1CDK2
SCHEMBL394705 0.74 ASH1L (0.52) RAB9ANPC1
SCHEMBL2156336 0.74 HTT (0.51) KDM4EALDH1A1HPGDL3MBTL1MAPK1
SCHEMBL3000703 0.73 MAT2A (0.40) KDM4EALDH1A1HPGDL3MBTL1MAPT
SCHEMBL2986580 0.71 SLC6A3 (0.39) KDM4ERAB9ANPC1MAPTCSF1R
SCHEMBL30990255 0.71 HPGD (0.40) KDM4EALDH1A1HPGDL3MBTL1RAB9A
SCHEMBL2863602 0.69 HPGD (0.37) KDM4EALDH1A1HPGDL3MBTL1RAB9A
SCHEMBL2156623 0.67 HPGD (0.38) KDM4EALDH1A1HPGDL3MBTL1RAB9A
SCHEMBL2157682 0.66 KDM4E (0.37) KDM4EALDH1A1HPGDL3MBTL1RAB9A
SCHEMBL6068829 0.64 CA12 (0.41) KDM4EALDH1A1HPGDRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973026-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-05 US disclosed
US-20090105227-A1 Thienopyrroles As Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105227-A1 Thienopyrroles As Antiviral Agents ZC3HAV1, HAVCR2, ZC3HAV1L KDM4E 3275/4885ALDH1A1 433/4885HPGD 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.